GraMedica® was founded by Dr. Michael E. Graham, a successful, Michigan-based doctor of podiatric medicine. Frustrated by the limitations of available treatment options on the market, Dr. Graham was determined to improve patient outcomes by providing revolutionary solutions.
In his practice, Dr. Graham specialized in correction of foot and ankle instability, a root cause of many secondary conditions throughout the body. It had long been known that the underlying cause of many foot and ankle problems is excessive hindfoot motion. To answer this challenge, Dr. Graham invented HyProCure®, an Extra-Osseous TaloTarsal Stabilization (EOTTS) Device.
This pioneering device is placed deep into the canalis portion of the sinus tarsi, reestablishing the normal pivot over which the talus (ankle bone) glides, thereby properly realigning the foot and ankle bones and restoring normal function. HyProCure® received FDA approval on September 16, 2004. The first HyProCure® placement took place on September 22, 2004. As more and more doctors and patients gained awareness of both the condition and treatment, the company grew rapidly. In July 2011, GraMedica® received FDA clearance for its second implantable device, osteo-WEDGETM, a revolutionary treatment option for moderate to severe bunion correction.
Through its sister organization, the Graham International Implant Institute (GIII), GraMedica® is committed to research, training, certification and support on implantology for foot physicians worldwide.
GraMedica® continues to develop additional product lines to support its mission of “Changing lives, one step at a time,” though innovation, quality, value and positive outcomes.
“With the support of my great team, I am proud of what we have been able to accomplish. Growth, responsibility, accountability, motivation, education, dedication, integrity, customer satisfaction and accountability – that’s what GraMedica® stands for and this is the reason we will continue to grow and lead” said Graham.
Foot and ankle surgeons are invited to learn more about the GraMedica® and their products at http://www.GraMedica.com, where they can also train online and/or find a live surgical training seminar in their area. Join GraMedica®’s network at http://www.linkedin.com/
Potential surgical candidates can find out more about GraMedica®’s pioneering product, HyProCure® and the devastating effects of talotarsal dislocation at http://www.HyProCure.com. Find a local HyProCure® specialist through the physician locator at www.HyProCure.com/
Susan Doherty, Director, Education & Physician Resources